數位生物標記的創新與成長機遇

Innovations and Growth Opportunities in Digital Biomarkers

出版日期: 2026年08月25日 | 出版商:

Frost & Sullivan | 英文 59 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

數位生物標記是指透過穿戴式裝置、植入式裝置、靜脈注射感測器、智慧型手機和行動應用程式等數位裝置和科技收集的有關生理功能和行為的可測量數據。

這些生物標記能夠持續、即時地提供有關個人健康狀況的信息，並用於監測正常的生物過程、疾病進展以及對治療和乾預的反應。

數位生物標記正進入更深層的整合和成熟階段。它們的未來在於「多模態多模態」，這種標記結合了生理功能、運動、行為和語音等多種數據流，從而創建能夠更全面反映健康狀況的複雜指標。

隨著法律規範的演變和現實世界證據的積累，數位生物標記有可能從實驗工具發展成為值得信賴的臨床工具，從而實現更早的干預、更好的治療效果以及對人類健康的更持續的了解。

數位生物標記具有巨大的潛力，能夠透過幫助個人更好地了解和追蹤自身健康狀況，從而變革醫療保健服務模式。這將有助於推行更積極主動的預防性醫療保健方法，使早期療育和護理管理不再局限於傳統的醫院環境。此外，數位生物標記還能提供持續的即時健康數據，進而加強醫病關係。

數位生物標記專利分析：全球市場，2023-2026年
數位生物標記領域的私部門資金籌措活動（全球，2023-2026 年）
數位生物標記領域的公共資金籌措趨勢（全球，2023-2026 年）
2023-2026年全球數位生物標記策略夥伴關係
數位生物標記領域全球策略拓展舉措（2023-2026年）
分析師對數位生物標記領域利益相關人員活動的看法

成長機會概述

成長機會1：利用穿戴式感測器和運動相關的數位生物標記物進行持續監測
成長機會 2：拓展人工智慧驅動的預測分析，用於疾病早期檢測
成長機會 3：多模態數位生物標記與數位遠距醫療平台的整合

附錄

技術成熟度等級（TRL）：說明

未來計劃

成長機會的益處和影響
未來計劃
免責聲明

簡介目錄

Product Code: DBA6-34

A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications.

These biomarkers provide continuous, real-time insights into an individual’s health status and are used to monitor normal biological processes, disease progression, and responses to treatment or interventions.

Digital biomarkers are entering a phase of deeper integration and maturity. The future lies in multi-modal biomarkers, where multiple data streams such as physiology, movement, behavior, and speech are combined into composite measures that reflect health more holistically.

As regulatory frameworks evolve and real-world evidence grows, digital biomarkers have the potential to move from experimental tools to trusted clinical instruments, enabling earlier intervention, better outcomes, and a more continuous understanding of human health.

Digital biomarkers have significant potential to transform healthcare delivery by enabling individuals to better understand and track their health conditions. This supports a more proactive and preventive healthcare approach, allowing earlier intervention and care management beyond traditional hospital settings. In addition, digital biomarkers can enhance the relationship between patients and healthcare providers by delivering continuous, real-time health data.

Cardiology Digital Biomarkers: Segment Analysis

Growth Restraints
Cardiology Digital Biomarkers - Overview
Comprehensive Overview of Unmet Needs in Cardiology Care and Clinical Development
Key Players Involved in Cardiology Digital Biomarkers
Key Academic Players Involved in Cardiology Digital Biomarkers

Neurology Digital Biomarkers: Segment Analysis

Neurology Digital Biomarkers - Overview
Key Components of Neurology Digital Biomarkers
Integrated Digital Biomarker Framework for Neurology
Key Players Involved in Neurology Digital Biomarkers
Key Academic Players Involved in Neurology Digital Biomarkers

Stakeholder Activities: Insights on Funding, Partnerships, and Acquisitions

Patent Analysis For Digital Biomarkers, Global, 2023-2026
Private Funding Activities In Digital Biomarkers Landscape, Global, 2023-2026
Public Funding Activities in Digital Biomarkers Landscape, Global, 2023-2026
Strategic Partnerships Shaping Digital Biomarkers, Global, 2023-2026
Strategic Expansion Initiatives for Digital Biomarkers, Global, 2023-2026
Analyst Insights on Stakeholder Activities in Digital Biomarkers

Growth Opportunity Universe

Growth Opportunity 1: Utilizing Wearable Sensors and Movement-Related Digital Biomarkers for Continuous Monitoring
Growth Opportunity 2: Expanding AI-Driven Predictive Analytics for Early Disease Detection
Growth Opportunity 3: Integrating Multi-Modal Digital Biomarkers with Digital Remote Care Platforms